Skip to main content
Clinical Trials/ISRCTN03576945
ISRCTN03576945CompletedNot Applicable

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on Hepatitis B antibody levels

ational Institute for Public Health and the Environment (RIVM) (Netherlands)0 sites597 target enrollmentStarted: August 14, 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
597

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Healthy young health care students from the Hogeschool of Utrecht, who are routinely vaccinated against hepatitis B
  • 2. 18 years or older, both male and female
  • 3. Written informed consent

Exclusion Criteria

  • 1. NSAIDs or paracetamol use within 48 hours before vaccination
  • 2. History of acute or chronic hepatitis B
  • 3. Earlier vaccination against hepatitis B
  • 4. Medical immunosuppressive treatment
  • 5. Primary or secondary immunodeficiency
  • 6. Allergic reaction to components of the hepatitis B vaccination or paracetamol

Investigators

Sponsor
ational Institute for Public Health and the Environment (RIVM) (Netherlands)

Similar Trials